Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7428 p631
25 November 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


WHO launches global plans to deal with counterfeiting problem

Global plans to tackle drugs counterfeiting were launched last week by the World Health Organization.

The plans, developed by the International Medical Products Anti-counterfeiting Taskforce (IMPACT) includes proposals for legislation, enforcement, regulation, technology and communicating risk.

“Without changes and improvements in those key areas we will not succeed in the fight against counterfeits,” said Howard Zucker, WHO assistant director-general for health technology and pharmaceuticals.

The latest estimates are that more than 30 per cent of medicines in some areas of Latin America, south east Asia and sub-Saharan Africa are counterfeit.

In emerging economies, the proportion is estimated at 10 per cent, but in many of the former Soviet republics it can be as high as 20 per cent. Less than 1 per cent of medicines in wealthy countries are believed to be counterfeit, apart from internet sales, where counterfeits account for 50 per cent of transactions.

In a press statement, the WHO said that the legal systems of most countries with laws designed to protect trademarks, rather than health, consider the seriousness of medicines counterfeiting to be on a par with counterfeiting handbags or wristwatches.

“A major objective is for countries to agree that [drug] counterfeiting is a crime against human security and to incorporate that principle into their laws,” said Dr Zucker.

The IMPACT was launched earlier this year (PJ, 25 February, p226) and has been able to develop its plan in only a few months. Organisers hope that all 193 WHO member states will be formally collaborating by the end of 2007 to stem counterfeiting.

European statistics Last year’s annual statistics on counterfeits intercepted on their way into the EU include medicines as a separate category for the first time.

In 2005, EU customs officials intercepted 148 consignments of counterfeit medicines and seized over half a million separate items. Most counterfeit medicines intercepted came from Indonesia, but the greatest number of individual consignments came from India.

One of the seized products was made from brick dust coated with yellow road paint and furniture polish. Counterfeit medicines amounted to 1 per cent of all recorded interceptions of counterfeit goods.

Counterfeit clothing and accessories account for 64 per cent of interceptions and 15 per cent of seizures. In contrast counterfeit cigarettes account for 1 per cent of interceptions and 43 per cent of seizures.

Back to Top


©The Pharmaceutical Journal